NWP
SNDX icon

Northstar Wealth Partners’s Syndax Pharmaceuticals SNDX Stock Holding History

Northstar Wealth Partners’s Portfolio SNDX Stock Details SNDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$162K Hold
11,000
– – 0.08% 141
2020
Q2 		$163K Hold
11,000
– – 0.07% 178
2020
Q1 		$120K Buy
+11,000
New +$103K 0.06% 159

Other funds holding SNDX

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BI
BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
MAM
MPM Asset Management Boston, Massachusetts $44.5M AUM 47.28% 1-Year Est. Return
Adage Capital Partners
Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
NCM
Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return
FM
Frazier Management Seattle, Washington $1.12M AUM 151.58% 1-Year Est. Return

Northstar Wealth Partners's SNDX Position: Q3 2020 in Review

Northstar Wealth Partners held its Syndax Pharmaceuticals (SNDX) position steady in Q3 2020 at 11,000 shares worth $162K. The position accounts for 0.08% of the portfolio, ranked #141.

Northstar Wealth Partners first reported a position in SNDX in Q1 2020 and has held it in 3 quarters since. The position peaked at $163K in Q2 2020. 99 funds tracked by Wall St. Rank hold SNDX as of Q3 2020.

  • Northstar Wealth Partners held 11,000 shares of Syndax Pharmaceuticals worth $162K as of Q3 2020.
  • Northstar Wealth Partners left its Syndax Pharmaceuticals share count unchanged in Q3 2020.
  • Syndax Pharmaceuticals made up 0.08% of Northstar Wealth Partners's portfolio in Q3 2020, its #141 holding.
  • Northstar Wealth Partners first reported a position in Syndax Pharmaceuticals in Q1 2020 and has held it in 3 quarters since.
  • Northstar Wealth Partners's Syndax Pharmaceuticals position peaked at $163K in Q2 2020.
  • 99 funds tracked by Wall St. Rank held Syndax Pharmaceuticals as of Q3 2020.

Based on Northstar Wealth Partners's 13F filing for Q3 2020, filed 13 Nov 2020.